Defibrillator Market Research, 2030
The global defibrillator market size was valued at $13,168 million in 2020, and is projected to reach $24,608.3 million by 2030, registering a CAGR of 6.6% from 2021 to 2030. Growing focus towards public access defibrillator (PAD) by the public and private organizations has fueled the market growth. Moreover, increase in number of key players to develop advanced defibrillator devices, rapidly growing geriatric population with elevated risk of cardiac arrest and increase in incidence of cardiac diseases further drive the market growth. Defibrillators are capable of performing cardioversion, defibrillation, and pacing of the heart. External defibrillators are of three major types, namely manual external defibrillator, automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs). AEDs are used for the treatment of sudden cardiac arrest (SCA) due to its high efficiency and ease in use, thereby bagging a large market share in the global defibrillator market. However, increase in pricing pressure on players is restraining the growth of the defibrillator market.
Market Introduction and Definition
Defibrillator is defined as a medical devices used to deliver therapeutic shock to a patient’s heart in life-threatening conditions, such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse. External defibrillators are life-saving medical devices used to deliver defibrillating shock through paddles or electrode pads to diagnose and restore life-threatening abnormal heart rhythms in the conditions of unexpected cardiac arrest.
The increase in adoption of technologically advanced defibrillators devices, growing demand for quality medical care, and rise in prevalence of SCA are key factors for the growth of the defibrillator market. The increase in focus and availability of defibrillators in offices, schools, shopping malls, grocery stores, and airports propel the market growth. Furthermore, increase in focus of key market players on public access defibrillators and increase in number of training & awareness programs across the globe are a few more factors driving the growth of the defibrillator.,
Advancement in the innovation of the next-generation external defibrillators to improve safety and effectiveness, are anticipated to create lucrative opportunities. Defibrillators aim to enhance the ability of the industry, identifying and addressing problems associated with devices. SCA is the leading cause of death globally, which is a life-threatening condition. It can be treated successfully by early intervention of the disease with defibrillation at the right time. The global external defibrillator market is dominated by automated external defibrillators (AEDs) and expected to grow with highest rate in future due to increase in adoption by heart failure patients across the globe. The increasing installations of public access AEDs have fueled the market growth. The second-largest market of external defibrillators is covered by manual external defibrillators followed by wearable external defibrillators.
Market Segmentation
The defibrillator market in this report is studied on the basis of product, end user, and region. On the basis of product, the market is divided into implantable defibrillators and external defibrillators. Implantable defibrillators are classified into transvenous implantable cardioverter defibrillator (T-ICDs), subcutaneous implantable cardioverter defibrillator (S-ICDs), and cardiac resynchronization therapy- defibrillator (CRT-D). External defibrillators are further classified as manual external defibrillator, automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs). On the basis of end user, the market is segregated into hospitals, pre-hospital, public access market, alternative care, and home. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By Product
Implantable Defibrillators segment held a dominant position in 2020.
Segment Review
By product, the implantable defibrillators segment currently dominates the global defibrillator market and is expected to continue during the forecast period owing to rapid increase in geriatric population, emergence of new technologies, increase in adoption of S-ICDs, and rise in incidence of sudden cardiac arrest (SCA). However, the external defibrillators segment is expected to witness considerable growth during the forecast period, owing to advancements in technology in the healthcare sector and rise in adoption of external defibrillators installations.
By end users, the hospitals segment dominated the global defibrillator market in 2020 and is anticipated to be dominant in the market owing to higher number of cardiac patients received in hospitals and surgeries performed in hospital settings. Both, ICDs and external defibrillators are increasingly used in hospitals to deliver treatment to patients of sudden cardiac arrest and for other indications. However, the alternative care segment is expected to witness considerable growth during the forecast period, owing to increase in demand for early diagnosis and initiative taken by government or private organizations for development of alternative care system.
By End User
Hospital segment held a dominant position in 2020.
Regional/Country Market Outlook
North America garnered a major share in the defibrillator market in 2020, and is expected to continue to dominate during the forecast period, owing to initiatives by key players, favorable regulations, and technologically advanced healthcare facilities in the U.S. and Canada. However, Asia-Pacific is expected to register highest CAGR of 8.2% from 2021 to 2030, owing to developing healthcare infrastructure, high patient population, and prevalence of cardiac diseases.
Competitive Landscape
The major companies profiled in this report include Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.
By Region
Asia- Pacific region would exhibit the fastest CAGR of 8.2% during the forecast period.
Key Benefits for Stakeholders
- The study provides an in-depth analysis of the global defibrillator market along with the current trends and future estimations to explain the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the defibrillator market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing defibrillator market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the application and products of defibrillators used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the defibrillator market.
Defibrillators Market Report Highlights
| Aspects | Details |
 By Product |
|
 By End User |
|
 By Region |
|
 By Key Market Players |
|
Analyst Review
The defibrillators market has witnessed sizeable growth in the recent years, owing to factors such as rise in incidence of chronic heart diseases and increase in awareness about the development of defibrillators to prevents sudden cardiac arrest (SCA) in patients sustained with ventricular tachycardia or atrial fibrillation. The increase in installations of defibrillators in hospitals and research centers, growth in incidence of cardiac arrhythmia, and rise in awareness regarding the lifesaving potential of defibrillators fuel the market growth.
Competitors in the market launch technologically advanced defibrillators to gain a competitive edge. In the public access market, defibrillators are used in schools & stadiums, corporate offices, government & community centers, hotels & restaurants, transportation, and health clubs.
However, lack of awareness about SCA and product recalls are the major factors that hinder the growth of the global defibrillators market.
The recommendation for the usage of defibrillators has rapidly increased the adoption rate in the developed economies. Moreover, the rationalizing use of defibrillator, is expected to drive the market growth during the forecast period.
The total market value of defibrillators market is $13,168 million in 2020.
The forecast period in the report is from 2021 to 2030
The market value of defibrillators Market in 2021 was $13,800.1 million
The base year for the report is 2020.
Yes, defibrillators companies are profiled in the report
The top companies that hold the market share in defibrillators market are Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.
Asia-Pacific is expected to register highest CAGR of 8.2% from 2021 to 2030, owing to increase in prevalence of atrial fibrillation, advancements in technology in the field of defibrillator, and initiatives taken by governments to enhance healthcare infrastructure
The key trends in the defibrillators market are increase in prevalence of cardiac arrhythmia, rise in geractric population and advancement in technology to manufacture defibrillators devices
Loading Table Of Content...
